Enliven Therapeutics, Inc. (ELVN): SCHEDULE 13D/A filed Jun 24, 2026

Form type

SCHEDULE 13D/A

Filing date

Jun 24, 2026

Accession number

0000947871-26-000651

Filer

Enliven Therapeutics, Inc. (CIK 1672619)